AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT made as of the 1st day of November, 1999 ("Employment Agreement") between EPIGEN, INC., a Delaware corporation, North Tower Hill Road, PO Box L, Millbrook, NY 12545 (the "Company"),...Employment Agreement • March 30th, 2000 • Epigen Inc /De • In vitro & in vivo diagnostic substances • New York
Exhibit 10.2 AGREEMENT BETWEEN EPIGEN, INC. AND VACOLD, LLC. Epigen, Inc, a Delaware Corporation with an office at North Tower Hill Road, PO Box L, Milbrook, NY 12545 ("Epigen"), is engaged in the development and commercialization of products for the...Agreement • August 12th, 1999 • Epigen Inc /De • In vitro & in vivo diagnostic substances • New York
AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT ("Employment Agreement") made as of November 1, 1999, between EPIGEN, INC.,a Delaware corporation, of Millbrook, New York (the "Company"), and DONALD C. FRESNE...Employment Agreement • March 30th, 2000 • Epigen Inc /De • In vitro & in vivo diagnostic substances • New York
1 2 5. Termination. This Agreement may be terminated by either party hereto as follows:Research Support Agreement • June 9th, 1998 • Epigen Inc /De • In vitro & in vivo diagnostic substances • New York
RECITALSSecurity and Intercreditor Agreement • August 8th, 2000 • Epigen Inc /De • In vitro & in vivo diagnostic substances • New York
RECITALSSecurity and Intercreditor Agreement • May 11th, 2000 • Epigen Inc /De • In vitro & in vivo diagnostic substances • New York
December 16, 1999 Thomas J. McQuaid, CPA Assistant Director and CEO Boston Biomedical Research Institute, Inc. 20 Staniford Street Boston, MA 02114 Re: Restated Agreement dated as of February 25, 1992 ------------------------------------------------...Epigen Inc /De • March 30th, 2000 • In vitro & in vivo diagnostic substances
May 4, 1999 Mr. W. James Tozer, Jr. Vectra Management Group 65 East 55th Street New York, New York 10022-3219 Re: Acquisition of Securities of Epigen, Inc. ("Epigen") ---------------------------------------------------- Dear Jim: The purpose of this...Epigen Inc /De • June 15th, 1999 • In vitro & in vivo diagnostic substances
The purpose of this letter is to set forth our mutual understanding regarding the scope of your investment in Epigen in light of your recent contribution of $250,000 to the capital of Epigen.
